Table 4 Perceived influence of price strategy on physicians’ prescribing behavior in hospitals of Dessie, Ethiopia (n = 136)
No | Description | SDa N (%) | Da N (%) | Na N (%) | Aa N (%) | SAa N (%) | Mean ± SD |
|---|---|---|---|---|---|---|---|
1 | Disclosure of actual price of the product | 3 (2.2) | 8 (5.9) | 32 (23.5) | 54 (39.7) | 39 (28.7) | 3.87 ± 0.97 |
2 | Price discounts technique for the product | 1 (0.7) | 19 (14) | 31 (22.8) | 53 (39) | 32 (23.5) | 3.71 ± 1.00 |
3 | Price of the drug and effectiveness of therapy | 1 (0.7) | 9 (6.6) | 14 (10.3) | 60 (44.1) | 52 (38.2) | 4.13 ± 0.89 |
4 | Price of medication in relation to quality | 2 (1.5) | 20 (14.7) | 30 (22.2) | 46 (33.8) | 38 (27.9) | 3.72 ± 1.07 |
5 | Price competition among pharmaceutical company | 6 (4.4) | 24 (17.6) | 46 (33.9) | 38 (27.9) | 22 (16.2) | 3.34 ± 1.08 |
6 | Price for full course therapy | 10 (7.4) | 14 (10.3) | 22 (16.1) | 61 (44.9) | 29 (21.3) | 3.63 ± 1.14 |